PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW144681View Pathway |
drug action
Carbamazepine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:12 Last Updated: October 07, 2023 at 14:12 |
PW147112View Pathway |
Carbachol Drug Metabolism PathwayHomo sapiens
Gadoversetamide is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Gadoversetamide passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: October 11, 2023 at 09:29 Last Updated: October 11, 2023 at 09:29 |
PW124507View Pathway |
Captopril metabolic pathwayHomo sapiens
Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Captopril may be used in the treatment of hypertension. (DrugBank)
Major metabolites are captopril-cysteine disulfide and the disulfide dimer of captopril. Metabolites are produced by Cytochrome P450 3A4 in the liver and may undergo reversible interconversion. These metabolites are excreted via the Organic anion transporter 1 (OAT1).
|
Creator: Dorsa Yahya Rayat Created On: February 03, 2021 at 16:26 Last Updated: February 03, 2021 at 16:26 |
PW145284View Pathway |
drug action
Captopril Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:28 Last Updated: October 07, 2023 at 15:28 |
PW122477View Pathway |
drug action
Captopril Action Pathway (ACEI)Homo sapiens
Captopril, brand name Capoten, belongs to the class of drugs known as angiotensin-converting enzyme (ACE) inhibitors and is used primarily to lower high blood pressure (hypertension). This drug can also be used in the treatment of congestive heart failure and type II diabetes. Unlike other ACE inhibitors, Captopril is not a prodrug. Angiotensin-converting enzyme (ACE) is a component of the body's renin–angiotensin–aldosterone system (RAAS) and cleaves inactive angiotensin I into the active vasoconstrictor angiotensin II. ACE (or kininase II) also degrades the potent vasodilator bradykinin. Consequently, ACE inhibitors decrease angiotensin II concentrations and increase bradykinin concentrations resulting in blood vessel dilation and thereby lowering blood pressure. Captopril is transported through the membrane and into the blood cells by solute carrier family 15 member 1 and solute carrier family 22 member 6. Multidrug resistance protein 1 transports captopril back through the membrane to later be renally excreted. Symptoms targeted by this drug are primarily high blood pressure, as well as congestive heart failure and type II diabetes. Side effects of this drug are cough, dizziness, headache, etc.. Affected organs are the heart and kidneys. Captopril is removed from the body through renal excretion.
|
Created On: April 29, 2019 at 09:39 Last Updated: April 29, 2019 at 09:39 |
PW000224View Pathway |
drug action
Captopril Action PathwayHomo sapiens
Benazepril, brand name Lotensin, belongs to the class of drugs known as angiotensin-converting enzyme (ACE) inhibitors and is used primarily to lower high blood pressure (hypertension). This drug can also be used in the treatment of congestive heart failure and type II diabetes. Benazepril is a prodrug which, following oral administration, undergoes biotransformation in vivo into its active form benazeprilat via cleavage of its ester group by the liver. Angiotensin-converting enzyme (ACE) is a component of the body's renin–angiotensin–aldosterone system (RAAS) and cleaves inactive angiotensin I into the active vasoconstrictor angiotensin II. ACE (or kininase II) also degrades the potent vasodilator bradykinin. Consequently, ACE inhibitors decrease angiotensin II concentrations and increase bradykinin concentrations resulting in blood vessel dilation and thereby lowering blood pressure.
|
Creator: WishartLab Created On: August 22, 2013 at 10:45 Last Updated: August 22, 2013 at 10:45 |
PW145782View Pathway |
drug action
Capsaicin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:38 Last Updated: October 07, 2023 at 16:38 |
PW144441View Pathway |
drug action
Capreomycin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:38 Last Updated: October 07, 2023 at 13:38 |
PW127873View Pathway |
drug action
Capreomycin Action PathwayHomo sapiens
Capreomycin, also known as Capastat, is an antibiotic from the aminoglycoside class. It is used as an adjunct drug in drug-resistant tuberculosis (TB). Like many antibiotics, this drug is produced by a bacteria, Streptomyces capreolus. Capreomycin's exact mechanism of action is still unclear, but it is thought to bind the 70S ribosomal unit of bacteria. It binds to the 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA. With this binding, the 16S rRNA can't interact with the 23S rRNA, this inhibits the translocation during the peptide elongation. Also, this drug affects protein synthesis by stabilizing the peptidyl-tRNA complex in the pretranslocation complex. Capreomycin is not absorbed in significant quantities from the gastrointestinal tract and must be administered parenterally (intramuscular or intravenous). The side effects are tinnitus, hearing loss, proteinuria, and renal dysfunction. As Mycobacterium Tuberculosis enters several cell types (neutrophils, macrophages, and endothelial cells) by phagocytosis, the drug is given by injection (intramuscular or intravenous).
|
Creator: Daphnee Created On: June 13, 2023 at 15:37 Last Updated: June 13, 2023 at 15:37 |
PW146449View Pathway |
drug action
Capmatinib Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:14 Last Updated: October 07, 2023 at 18:14 |